Hao Zeng

3.6k total citations
117 papers, 2.5k citations indexed

About

Hao Zeng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Hao Zeng has authored 117 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 44 papers in Molecular Biology and 34 papers in Oncology. Recurrent topics in Hao Zeng's work include Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Renal cell carcinoma treatment (13 papers). Hao Zeng is often cited by papers focused on Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Renal cell carcinoma treatment (13 papers). Hao Zeng collaborates with scholars based in China, United States and Finland. Hao Zeng's co-authors include Gary D. Kruh, Martin G. Belinsky, Zhe‐Sheng Chen, Philip A. Rea, Kun Hee Lee, Qiao Zhou, Xueqin Chen, Irina Shchaveleva, Rebecca B. Raftogianis and Susan Walther and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hao Zeng

104 papers receiving 2.4k citations

Peers

Hao Zeng

ONCOL

PRM

PPCH

Weina Chen United States

Surapol Issaragrisil Thailand

Jinbo Chen China

Najmaldin Saki Iran

Vikram Mathews India

Holger Rumpold Austria

Andrea Gsur Austria

Jan S. Moreb United States

Bing Xu China

Friedemann Honecker Germany

Weina Chen United States

Hao Zeng

801 ×0.7

ONCOL

1.7k ×1.9

620 ×1.2

190 ×0.4

PRM

126 ×0.3

PPCH

Citations per year, relative to Hao Zeng Hao Zeng (= 1×) peers Weina Chen

Countries citing papers authored by Hao Zeng

Since Specialization

Citations

This map shows the geographic impact of Hao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Zeng more than expected).

Fields of papers citing papers by Hao Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Zeng. The network helps show where Hao Zeng may publish in the future.

Co-authorship network of co-authors of Hao Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Zeng. A scholar is included among the top collaborators of Hao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Zeng. Hao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Chengyu, Yangwu Chen, Hao Zeng, et al.. (2025). Real-time ATP monitoring revolutionizing wastewater treatment: Improving effluent quality prediction based on microbial activity. Process Safety and Environmental Protection. 201. 107614–107614.

Zeng, Hao, Ruiheng Liu, Yuanjia Liu, et al.. (2025). Microplastics in animal-derived products and their potential risks to human health. TrAC Trends in Analytical Chemistry. 185. 118187–118187. 6 indexed citations

Chen, Junru, Guangxi Sun, Xingming Zhang, et al.. (2025). The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate. The Prostate. 85(7). 659–669.

Jiao, Jianlin, Yi Han, Hao Zeng, et al.. (2025). Tree shrew as a new animal model for musculoskeletal disorders and aging. Bone Research. 13(1). 5–5. 2 indexed citations

Zhao, Jinge, Junru Chen, Jiayu Liang, et al.. (2025). Urogenital Manifestations in Mpox (Monkeypox) Infection: A Comprehensive Review of Epidemiology, Pathogenesis, and Therapeutic Approaches. Infection and Drug Resistance. Volume 18. 209–226. 2 indexed citations

Pan, Xiuyi, Linmao Zheng, Mengxin Zhang, et al.. (2025). Fumarate activates the IL-6/JAK/STAT3 pathway by inhibiting KDM4C-mediated H3K36me3 demethylation in FH-knockdown renal cancer cells. British Journal of Cancer. 133(11). 1611–1624.

Huang, Gui‐Xiang, et al.. (2025). Data-Driven Recursive Kinetic Modeling for Fenton Reaction. Environmental Science & Technology. 59(45). 24473–24480.

Wang, Shunxiang, et al.. (2024). Comparison of mechanical strengths and microstructure of Portland cement-calcium sulfoaluminate cement binders with cellulose ethers of different viscosities. Construction and Building Materials. 437. 137022–137022. 7 indexed citations

Zhao, Jinge, Ling Nie, Junru Chen, et al.. (2024). Assessing the predictive value of intraductal carcinoma of the prostate (IDC‐P) in determining abiraterone efficacy for metastatic hormone‐sensitive prostate cancer (mHSPC) patients. The Prostate. 85(2). 130–139.

10.

Paradkar, Sateja, Joseph Edmonds, Sam Friedman, et al.. (2024). NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. Molecular Cancer Research. 22(10). 973–988. 1 indexed citations

11.

Zhao, Jinge, et al.. (2024). Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents. Cancer Biology and Medicine. 21(11). 1012–1032. 7 indexed citations

12.

Chen, Junru, Guangxi Sun, Junjie Zhao, et al.. (2023). The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response. Cancer Medicine. 12(24). 22370–22380. 5 indexed citations

13.

Zhu, Sha, Yige Bao, Linmao Zheng, et al.. (2022). Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report. OncoTargets and Therapy. Volume 15. 947–952. 1 indexed citations

14.

Xiao, Yinan, et al.. (2020). Anticancer Effect of Natural Product Sulforaphane by Targeting MAPK Signal through miRNA-1247-3p in Human Cervical Cancer Cells. Biointerface Research in Applied Chemistry. 11(1). 7943–7972. 4 indexed citations

15.

Yin, Xiaoxue, Qiuyuan Xia, Linmao Zheng, et al.. (2020). Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. Journal of Clinical Pathology. 74(3). 171–176. 17 indexed citations

16.

Ling, Wenwu, Xuelei Ma, Yan Luo, et al.. (2017). Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion. Contrast Media & Molecular Imaging. 2017. 1–5. 5 indexed citations

17.

Huang, Rui, et al.. (2010). The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. Asian Journal of Andrology. 12(4). 527–534. 13 indexed citations

18.

Belinsky, Martin G., Zhe‐Sheng Chen, Irina Shchaveleva, Hao Zeng, & Gary D. Kruh. (2002). Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).. PubMed. 62(21). 6172–7. 201 indexed citations

19.

Kruh, Gary D., Hao Zeng, Philip A. Rea, et al.. (2001). MRP Subfamily Transporters and Resistance to Anticancer Agents. Journal of Bioenergetics and Biomembranes. 33(6). 493–501. 129 indexed citations

20.

Zeng, Hao, Lisa J. Bain, Martin G. Belinsky, & Gary D. Kruh. (1999). Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents.. PubMed. 59(23). 5964–7. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact